Stobie L, Gurunathan S, Prussin C, Sacks D L, Glaichenhaus N, Wu C Y, Seder R A
Clinical Immunology Section, Laboratory of Clinical Investigation, Howard Hughes Medical Institute, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8427-32. doi: 10.1073/pnas.160197797.
IL-12 plays a central role in both the induction and magnitude of a primary Th1 response. A critical question in designing vaccines for diseases requiring Th1 immunity such as Mycobacterium tuberculosis and Leishmania major is the requirements to sustain memory/effector Th1 cells in vivo. This report examines the role of IL-12 and antigen in sustaining Th1 responses sufficient for protective immunity to L. major after vaccination with LACK protein (LP) plus rIL-12 and LACK DNA. It shows that, after initial vaccination with LP plus rIL-12, supplemental boosting with either LP or rIL-12 is necessary but not sufficient to fully sustain long-term Th1 immunity. Moreover, endogenous IL-12 is also shown to be required for the induction, maintenance, and effector phase of the Th1 response after LACK DNA vaccination. Finally, IL-12 is required to sustain Th1 cells and control parasite growth in susceptible and resistant strains of mice during primary and secondary infection. Taken together, these data show that IL-12 is essential to sustain a sufficient number of memory/effector Th1 cells generated in vivo to mediate long-term protection to an intracellular pathogen.
白细胞介素-12在初始Th1反应的诱导和强度方面均发挥核心作用。在为需要Th1免疫的疾病(如结核分枝杆菌和硕大利什曼原虫)设计疫苗时,一个关键问题是在体内维持记忆/效应Th1细胞的条件。本报告研究了白细胞介素-12和抗原在用LACK蛋白(LP)加重组白细胞介素-12以及LACK DNA接种疫苗后,维持足以对硕大利什曼原虫产生保护性免疫的Th1反应中的作用。结果显示,在用LP加重组白细胞介素-12进行初始接种后,用LP或重组白细胞介素-12进行补充加强是必要的,但不足以完全维持长期的Th1免疫。此外,内源性白细胞介素-12在接种LACK DNA疫苗后的Th1反应的诱导、维持和效应阶段也被证明是必需的。最后,在初次和二次感染期间,白细胞介素-12对于维持Th1细胞以及控制易感和抗性小鼠品系中的寄生虫生长是必需的。综上所述,这些数据表明,白细胞介素-12对于维持体内产生的足够数量的记忆/效应Th1细胞以介导对细胞内病原体的长期保护至关重要。